By expenditures
| Name | Title | Type |
|---|---|---|
| Ivy Melendez | Executive Director | Auditee |
| Anthony Polcari | Auditor | Auditee |
| Rich Larsen | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 360890 | 2024 | 2025-06-30 | Novogradac & Company LLP | $3.93M |
| 5939 | 2022 | 2023-12-08 | Polcari and Company CPAS | $4.69M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 360890 | 2024 | 2025-06-30 | 1145830 | 2024-003 | Material Weakness | Yes | N |
| 360890 | 2024 | 2025-06-30 | 1145829 | 2024-002 | Significant Deficiency | Yes | N |
| 360890 | 2024 | 2025-06-30 | 1145828 | 2024-001 | Significant Deficiency | Yes | N |
| 360890 | 2024 | 2025-06-30 | 1145827 | 2024-006 | Significant Deficiency | - | N |
| 360890 | 2024 | 2025-06-30 | 1145826 | 2024-005 | Material Weakness | - | N |
| 360890 | 2024 | 2025-06-30 | 1145825 | 2024-004 | Material Weakness | - | N |
| 360890 | 2024 | 2025-06-30 | 1145824 | 2024-002 | Significant Deficiency | Yes | N |
| 360890 | 2024 | 2025-06-30 | 569388 | 2024-003 | Material Weakness | Yes | N |
| 360890 | 2024 | 2025-06-30 | 569387 | 2024-002 | Significant Deficiency | Yes | N |
| 360890 | 2024 | 2025-06-30 | 569386 | 2024-001 | Significant Deficiency | Yes | N |
| 360890 | 2024 | 2025-06-30 | 569385 | 2024-006 | Significant Deficiency | - | N |
| 360890 | 2024 | 2025-06-30 | 569384 | 2024-005 | Material Weakness | - | N |
| 360890 | 2024 | 2025-06-30 | 569383 | 2024-004 | Material Weakness | - | N |
| 360890 | 2024 | 2025-06-30 | 569382 | 2024-002 | Significant Deficiency | Yes | N |
| 5939 | 2022 | 2023-12-08 | 580200 | 2022-001 | Material Weakness | - | E |
| 5939 | 2022 | 2023-12-08 | 3758 | 2022-001 | Material Weakness | - | E |